What does the evidence say about Probiotics Digestive Symptoms Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Probiotics Digestive Symptoms Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - This review summarizes the current concepts of probiotics and evaluates evidence supporting their use in patients with lower GI disorders, with a focus on potential sex-related differences. [Kim Yong Sung (2026); evidence level 2] - Saccharomyces, Lactobacillus Bifidobacterium Clostridium difficile 7 This review was conducted to summarize and interpret the current evidence on probiotics on IBS, FC, and CDI in terms of sex differences. [Kim Yong Sung (2026); evidence level 2] - Overall, probiotics significantly increased spontaneous bowel movement (SBM) per week by 0.67 (95% CI, 0.22-1.12) at 4 weeks after ingestion (). [Kim Yong Sung (2026); evidence level 2] - Clostridioides difficile 1 3 - 4 5 4 6 - For over a century, probiotics have been widely consumed as fermented beverages and supplements to promote gut health. [Kim Yong Sung (2026); evidence level 2] - This bibliometric analysis was conducted and reported in accordance with the Guideline for Reporting Bibliometric Reviews of the Biomedical Literature (BIBLIO). [Shen Yirong (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.